SDI GROUP PLC — Director's Dealing 2018

Nov 1, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0833G

Scientific Digital Imaging Plc

01 November 2018

Scientific Digital Imaging plc

("SDI", the "Company" or the "Group")

(AIM: SDI)

Exercise of Options

Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets, announces the exercise of share options by Mike Creedon, Chief Executive Officer of the Company over 165,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") (the "Exercise").

100,000 of the share options have an exercise price of 13.0 pence; 50,000 of the share options have an exercise price of 12.5 pence and 15,000 of the share options have an exercise price of 21.5 pence. Following the Exercise, Mike Creedon has a total beneficial holding of 311,924 Ordinary Shares representing 0.35 per cent. of the issued share capital of the Company.

The 165,000 Ordinary Shares allotted pursuant to the Exercise have been transferred from the Synoptics Employee Benefit Trust. The Synoptics Employee Benefit Trust will now hold 160,528 Ordinary Shares representing approximately 0.18 per cent. of the issued share capital of the Company.

As a result, the issued share capital of the Company will remain unchanged at 89,633,424 Ordinary Shares and the total number of voting rights is also 89,633,424. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Scientific Digital Imaging plc	01223 320480
Ken Ford, Chairman
Mike Creedon, CEO
Jon Abell, CFO
www.scientificdigitalimaging.com
finnCap Ltd	020 7220 0500
Ed Frisby/Kate Bannatyne - Corporate Finance
Andrew Burdis - Corporate Broking
JW Communications	07818 430877
Julia Wilson - Investor & Public Relations

About SDI:

Scientific Digital Imaging plc designs and manufactures scientific and technology products for use in applications including life sciences, healthcare, astronomy, consumer manufacturing and art conservation through the Synoptics brands (Syngene, Synbiosis, and Synoptics Health), the Atik brands (Atik Cameras, Opus Instruments and QSI), Sentek, Astles Control Systems and Applied Thermal Control. SDI intends to continue to grow through its own technology advancements as well as strategic, complementary acquisitions.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Creedon

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Scientific Digital Imaging plc

b)

LEI

213800YA3XW7JRE46Z70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1 pence each

Identification code

GB00B3FBWW43

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
13.0p 12.5p 21.5p	100,000 50,000 15,000

d)

Aggregated information:

·     Aggregated volume

·     Price

See 4c) above

e)

Date of the transaction

1 November 2018

f)

Place of the transaction

Outside of a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCEALFFELPPFFF